Opioid-prescribing considerations in patients with cancer and substance misuse or substance use disorder: a scoping review protocol.
Opioid-prescribing considerations in patients with cancer and substance misuse or substance use disorder: a scoping review protocol.
复制标题
癌症和物质滥用或物质使用障碍患者的阿片类药物处方注意事项：范围界定审查方案。
DOI：
10.11124/jbies-22-00007
复制
发表时间：
2023
影响因子：
2.7
通讯作者：
Merlin,JessicaS
中科院分区：
文献类型：
--
作者：
Jones,KatieFitzgerald;Malinowski,Jennifer;Paice,Judith;Childers,Julie;Bulls,HaileyW;Morrison,Jeni;Ho,JJanet;Alsbrook,Karen;Nugent,Shannon;Broglio,Kathleen;Nickels,Katrina;Holbein,Monika;Parajuli,Jyotsana;Merlin,JessicaS
目的：本范围审查的目的是描述现有文献中的因素，可能会告知阿片类药物处方决策的患者过去或现在的癌症史和过去或现在的物质滥用或物质使用disorder.Introduction：阿片类药物和阿片类药物相关的决定是癌症护理的关键组成部分。大多数癌症患者在癌症护理期间都会经历疼痛，超过一半的患者将接受阿片类药物处方。阿片类药物处方决定需要权衡利益和危害。物质滥用或物质使用障碍的存在可能会增加阿片类药物相关危害的风险，但在这一交叉点上缺乏对患者管理的共识。纳入标准：本次审查将考虑包括过去或现在有癌症史的成年患者的研究，这些患者也有疼痛和当前或历史的物质滥用或物质使用障碍。疼痛可能与癌症有关或非癌症有关。除非黑色素瘤皮肤癌外，所有类型癌症患者的研究都有资格入选。符合条件的研究将探讨因素，告知阿片类药物处方的决定，在这个patient population.Methods：审查将根据JBI方法进行范围审查。自数据库建立以来以英文撰写的研究报告将被纳入。检索的数据库包括MEDLINE（奥维德）、CINAHL（EBSCO）、Embase、阿帕PsycINFO和Google Scholar。合格研究将由2名独立审查员使用作者创建的数据提取工具进行数据提取。叙述性总结将描述研究特征、人群详情和用于确定患者人群中适当疼痛管理的策略。
Objective:This scoping review aims to describe factors in the existing literature that may inform opioid-prescribing decisions for patients with a past or present history of cancer and past or present substance misuse or substance use disorder.Introduction:Opioids and opioid-related decisions are critical components of cancer care. Most individuals with cancer will experience pain during cancer care, and over half of patients will receive an opioid prescription. Opioid-prescribing decisions require weighing the benefits and harms. The presence of substance misuse or substance use disorder may elevate the risk of opioid-related harms, but there is a lack of consensus on managing patients at this intersection.Inclusion criteria:This review will consider studies that include adult patients with a past or present history of cancer who also have pain and current or historical substance misuse or substance use disorder. The pain may be cancer-related or non-cancer-related. Studies of patients with all types of cancer will be eligible for inclusion, with the exception of non-melanoma skin cancers. Eligible studies will explore factors that inform opioid-prescribing decisions in this patient population.Methods:The review will be conducted according to JBI methodology for scoping reviews. Studies written in English since database inception will be included. The databases to be searched include MEDLINE (Ovid), CINAHL (EBSCO), Embase, APA PsycINFO, and Google Scholar. Eligible studies will undergo data extraction by 2 independent reviewers using a data extraction tool created by the authors. A narrative summary will describe study characteristics, population details, and strategies used to determine appropriate pain management in the patient population.